Drug/cyclodextrin: Beyond inclusion complexation

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 69, Issue 3-4, 2011, Pages 297-301

  Kurkov, Sergey V ^a   Ukhatskaya, Elena V ^a   Loftsson, Thorsteinn ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Aggregates; Cyclodextrins; Nanopaticles

Indexed keywords

EID: 79955977744     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9756-x     Document Type: Conference Paper

References (25)

1. Connors, K. A.: The stability of cyclodextrin complexes in solution. Chem. Rev. 97, 1325-1357 (1997) (Pubitemid 127659601)
2. Higuchi, T., Connors, K. A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965)
3. Aicart, E., Junquera, E.: Complex formation between purine derivatives and cyclodextrins: a fluorescence spectroscopy study. J. Incl. Phenom. Macrocycl. Chem. 47, 161-165 (2003) (Pubitemid 39023801)
4. Masson, M., Sigurjonsdottir, J. F., Jonsdottir, S., Loftsson, T.: Examination of 19F-NMR as a tool for investigation of drugcyclodextrin complexes. Drug Dev. Ind. Pharm. 29, 107-112 (2003) (Pubitemid 36205887)
5. Morin, N., Cornet, S., Guinchard, C., Rouland, J.-C., Guillaume, Y. C.: HPLC retention and inclusion of imidazole derivatives using hydroxypropyl- β-cyclodextrin as a mobile phase additive. J. Liq. Chromatogr. Relat. Technol. 23, 727-739 (2000) (Pubitemid 30163842)
6. Perlovich, G. L., Skar, M., Bauer-Brandl, A.: Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPCD. Eur. J. Pharm. Sci. 20, 197-200 (2003) (Pubitemid 37205212)
7. Masson, M., Loftsson, T., Jonsdottir, S., Fridriksdottir, H., Petersen, D. S.: Stabilization of ionic drugs through complexation with nonionic and ionic cyclodextrins. Int. J. Pharm. 164, 45-55 (1998) (Pubitemid 28160097)
8. Masson, M., Sigurdardottir, B. V., Matthiasson, K., Loftsson, T.: Investigation of drug-cyclodextrin complexes by a phase-distribution method: some theoretical and practical considerations. Chem. Pharm. Bull. 53, 958-964 (2005) (Pubitemid 41327688)
9. Ugwu, S. O., Alcala, M. J., Bhardwaj, R., Blanchard, J.: The application of equilibrium dialysis to the determination of drugcyclodextrin stability constants. J. Incl. Phenom. Mol. Recognit. Chem. 25, 173-176 (1996)
10. Loftsson, T., Magnusdottir, A., Masson, M., Sigurjonsdottir, J. F.: Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91, 2307-2316 (2002) (Pubitemid 35231194)
11. Kurkov, S. V., Loftsson, T., Messner, M., Madden, D.: Parenteral delivery of HPβCD: effects on drug-HSA binding. AAPS PharmSciTech (in press)
12. Magnusdottir, A., Masson, M., Loftsson, T.: Self association and cyclodextrin solubilization of NSAIDs. J. Incl. Phenom. Macrocycl. Chem. 44, 213-218 (2003)
13. Loftsson, T., Hreinsdottir, D., Masson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18-28 (2005) (Pubitemid 41244817)
14. Loftsson, T., Olafsdottir, B. J., Fridriksdottir, H., Jonsdottir, S.: Cyclodextrin complexation of NSAIDs: physicochemical characteristics. Eur. J. Pharm. Sci. 1, 95-101 (1993) (Pubitemid 24055793)
15. Oh, I., Lee, M.-Y., Lee, Y.-B., Shin, S.-C., Park, I.: Spectroscopic characterization of ibuprofen/2-hydroxypropyl-β-cyclodextrin inclusion complex. Int. J. Pharm. 175, 215-223 (1998) (Pubitemid 28517977)
16. Miyajima, K., Sawada, M., Nakagaki, M.: Viscosity B-coefficients, apparent molar volumes, and activity coefficients for aand γ-cyclodextrins in aqueous solutions. Bull. Chem. Soc. Jpn. 56, 3556-3560 (1983) (Pubitemid 14546889)
17. Bonini, M., Rossi, S., Karlsson, G., Almgren, M., Lo Nostro, P., Baglioni, P.: Self-assembly of-β-cyclodextrin in water. Part 1: cryo-TEM and dynamic and static light scattering. Langmuir 22, 1478-1484 (2006)
18. Szente, L., Szejtli, J., Kis, G. L.: Spontaneous opalescence of aqueous γ-cyclodextrin solutions: complex formation or selfaggregation? J. Pharm. Sci. 87, 778-781 (1998) (Pubitemid 28268581)
19. Witte, F., Hoffmann, H.: Aggregation behavior of hydrophobically modified-β-cyclodextrins in aqueous solution. J. Incl. Phenom. Mol. Recognit. Chem. 25, 25-28 (1996) (Pubitemid 126648414)
20. Auzely-Velty, R., Djedaieni-Pilard, F., Desert, S., Perly, B., Zemb, T.: Micellization of hydrophobically modified cyclodextrins. 1. Micellar structure. Langmuir 16, 3727-3734 (2000)
21. Loftsson, T., Matthiasson, K., Masson, M.: The effects of organic salts on the cyclodextrin solubilization of drugs. Int. J. Pharm. 262, 101-107 (2003) (Pubitemid 36966698)
22. Loftsson, T., Masson, M., Sigurdsson, H. H.: Cyclodextrins and drug permeability through semi-permeable cellophane membranes. Int. J. Pharm. 232, 35-43 (2002) (Pubitemid 34076752)
23. Messner, M., Kurkov, S. V., Loftsson, T.: Self-assembled cyclodextrin aggregates and nanoparticles. Int. J. Pharm. 387 (1-2), 199-208 (2010)
24. Jansook, P., Kurkov, S. V., Loftsson, T.: Cyclodextrins as solubilizers: formation of complex aggregates. J. Pharm. Sci. 99(2), 719-729 (2010)
25. Wu, A., Shen, X., He, Y.: Investigation on γ-cyclodextrin nanotube induced by N, N'-diphenylbenzidine molecule. J Colloid Interface Sci. 297, 525-533 (2006)